7.371 Biological and Engineering Principles Underlying Novel Biotherapeutics
Covers biological and bioengineering principles underlying the development and therapeutic use of recombinant proteins and immune cells. Special attention to monoclonal antibodies and engineered immune system cells as therapeutics; protein- and glyco- engineering to enhance protein function; protein pharmacology and delivery; nucleic acid- based biotherapeutics; generation of functional cells and tissues from embryonic stem cells and iPS cells; and immune cell-cancer cell interactions in cancer immunotherapy.
This class has 7.06 as a prerequisite.
This class counts for a total of 12 credits.
You can find more information at the http://www.google.com/search?&q=MIT+%2B+7.371&btnG=Google+Search&inurl=https site.
© Copyright 2015 Yasyf Mohamedali